Stryker Corporation

New York Stock Exchange
Back to all articles
Somewhat Bearish -45

Stryker stock falls on slower peripheral vascular, hip sales

AI-generated analysis

📉 Stryker shares dropped 9.7% after CFO Preston Wells reported slower peripheral vascular and hip sales during a healthcare conference.

⚠️ The company continues to face supply disruptions in its peripheral vascular business following a March cyberattack that impacted manufacturing and shipping operations.

📅 Supply issues expected to persist into the fourth quarter, delaying full capacity recovery for existing and new customers.

🦴 Hip sales underperformed due to a softer European market for joint replacements and seasonal factors in the U.S.

💸 Consumers are deferring elective procedures due to inflation concerns and higher insurance deductibles, creating a consumer challenge.

🛡️ Stryker maintained its financial guidance despite the operational headwinds and sales misses in key segments.

⚙️ Strong backorders for capital equipment are offsetting some of the weakness as the company catches up on post-cyberattack orders.

🤝 The integration of Inari Medical is facing ripple effects from the cyberattack, complicating manufacturing facility assimilation.

🏥 Stryker is prioritizing inventory allocation to ensure its top customers have sufficient stock for procedures.

Bullish Signals
  • Backorders for capital equipment remain strong as the company catches up on orders following the cyberattack, providing a counterbalance to segment weakness.
  • Stryker maintained its financial guidance unchanged despite reporting slower sales in peripheral vascular and hip segments.
Risk Factors
  • Peripheral vascular business supply issues persist into the fourth quarter due to lingering effects from a March cyberattack on manufacturing and shipping.
  • Hip sales were slower than expected, driven by a softer European market for joint replacements and U.S. seasonality.
  • Consumer demand is being suppressed as patients defer procedures due to inflation concerns and higher insurance deductibles.
  • The integration of Inari Medical is experiencing ripple effects from the cyberattack, hindering the assimilation of its manufacturing facility.
Full Analysis
Stryker Corporation (SYK) shares fell 9.7% following an update from CFO Preston Wells at the Wells Fargo Healthcare Conference, citing slower-than-expected sales in its peripheral vascular and hip segments. The company is still navigating supply chain disruptions within its peripheral vascular business that originated from a March cyberattack affecting manufacturing and shipping operations. Wells indicated that while some supply issues were hoped to be resolved by the third quarter, they may persist into the fourth quarter, limiting the firm's ability to fully supply existing customers and acquire new ones. Additionally, hip sales have been sluggish due to a softer year for joint replacements in Europe and slower U.S. performance attributed to seasonality, vacations, and consumers deferring procedures due to inflation concerns and higher insurance deductibles. Despite these challenges, Stryker maintained its financial guidance unchanged. The company is seeing strong demand and backorders for capital equipment as it catches up on orders following the cyberattack. Analysts note that while integrating the $4.9 billion Inari Medical acquisition has faced ripple effects from the security incident, the firm remains focused on rectifying inventory levels to prioritize top customers.